News

President Donald Trump's drug pricing order seeks to balance innovation with affordability, ending the burden on American ...
While the Trump administration’s latest executive order touts sweeping drug price cuts through international benchmarking, ...
ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to ...
(Reuters) -As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the ...
Cramer noted that investors are skirting Johnson & Johnson (NYSE: JNJ) because of worries regarding Robert Kennedy Jr., as he commented: ...
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big ...
Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know ...
The new executive order contains multiple provisions if pharmaceutical companies do not offer "most-favored nation" pricing ...
What a pity that a Republican administration needs to be reminded that this misguided policy won’t make America healthy or ...